The Role of “Doctor-Industry Dyad” in Decreasing Health Care Expenditures

Abstract

This paper presents an assessment of the doctor-industry relationship effect on generic drug prescription, and attempts to help policy makers and generic producers to establish more efficient programs when promoting generic drugs as a cost saving measure in healthcare provision. We followed a qualitative approach, using methodological and information sources triangulation in order to explore the current situation. The research findings end up with a clear framework to evaluate the impact of such relationship on improving the management and control of healthcare costs.